Questions about cancer? Freephone 1800 200 700 Irish Cancer Society Nurseline

About this trial

This study is being done to collect data regarding the impact of SARS-CoV-2 infection on patients with cancer, and on the functioning and organisation of cancer services in the Republic of Ireland in response to the 2020 SARS-CoV-2 pandemic.

The study will examine whether there are changes that cancer departments across Ireland could make in order to reduce the risks associated with coronavirus infections in people with cancer. It will also investigate whether any particular chemotherapies appear to increase or reduce the severity of infection among cancer patients diagnosed with COVID-19. This information will allow us to learn how to help cancer patients who may be at risk of developing coronavirus and help to plan chemotherapy treatments for cancer patients across Ireland.

Patient Profile

This study is open to men and women with cancer, over 18 years of age,  admitted at participating sites and who test positive for SARS-CoV-2 infection.

Where’s this trial being run?

Mater Misericordiae University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information


Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: COVID-IYON Study
Number: 20-01
Full Title:


Principal Investigator: Prof Linda Coate (University Hospital Limerick) and Dr Colm MacEochagain (University Hospital Limerick)
Type: In-House

Cancer Trials Ireland

Recruitment Started: Global: Not Applicable
Ireland: April 2020
Global Recruitment Target: Not Applicable
Ireland Recruitment Target: Not Applicable